Biocompatible SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery

Read full text
Authors: Tianxiong Mi, Lijun Fan, Amber L. Hackler, Diego B. Diaz, Chang Qi, Errol L. G. Samuel, Qi Gao, Tao Meng, Xingjian Xu, Erwin G. Abucayon, Edward N. DiNunzio, Marcelo J. Murai
+5 more Natalya Pissarnitski, Jordan De, Jesus Silva, Christopher Sondey, Jack D. Scott
Cited by: 1

Abstract

Rapid, aqueous macrocyclization strategies that proceed in high conversion are valuable for ultra-large macrocyclic peptide library synthesis via display and DNA-encoded library (DEL) technology. Here we report an on-DNA macrocyclization based on sulfur(VI) fluoride exchange (SuFEx) that unites above features. This approach embeds a phenol and an aryl sulfonyl fluoride within a DNA-tagged peptide to accelerate SuFEx and trigger intramolecular cyclization immediately upon dissolution in basic aqueous buffer. Macrocycles ranging from 15-to 52-membered rings bearing diverse amino acids were synthesized efficiently. The reaction integrates seamlessly into DEL workflows and enabled discovery of potent, de novo macrocyclic RIPK1 inhibitors. The on-DNA cyclization conditions readily translate off-DNA to furnish sulfonate-and sulfonamide-linked macrocycles. NMR analyses showed SuFEx-derived biaryl linkers act as conformational elements: changes in aryl substitution and linker length tune backbone conformations from extended strands to rigid turns. These findings establish SuFEx cyclization as a robust, biocompatible strategy for programmable macrocycle design and drug discovery.

Fields of Study & Subjects

Chemical Synthesis and Analysis Biochemical and Structural Characterization Supramolecular Self-Assembly in Materials

Publication details

Journal / source
ChemRxiv
Publisher
American Chemical Society (ACS)
Publication date
19 March 2026
Document type
Preprint